Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
11m agoBurnham Holdings, Inc. Reports Strong First Quarter 2026 Financial Results; Net Sales Surge 18.7% to $66.2 Million
11m ago"KAGURABACHI" Set for TV Anime Adaptation by Cypic in April 2027!
11m agoAscent Industries Sets First Quarter 2026 Earnings Conference Call for May 6, 2026, at 5:00 p.m. ET
11m agoRobert Half selected by Forbes as one of America's Best Employers for Company Culture 2026
12m agoMeridian Corporation Announces Appointment of Ken Warriner to Board of Directors
Ani Pharmaceuticals Inc logo

Ani Pharmaceuticals Inc

About

Ani Pharmaceuticals Inc (NASDAQ:ANIP) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 24 2026
ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET
Apr 20 2026
ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity
Apr 13 2026
ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules
Apr 8 2026
ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet
Apr 7 2026
ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology

Financials

Revenue
$883.37 M
Market Cap
$1.67 B
P/E Ratio
22.35
EPS
3.32

Community Chat

Ask AI

6ix6ix